Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Rimegepant
Vydura
Routinely available
SMC (SMC2603)
07/08/2024
Indication
For the preventive treatment of episodic migraine in adults who have at least four migraine attacks per month. SMC restriction: for patients with episodic migraine who have at least 4 migraine attacks per month, but fewer than 15 headache days per month and who have had prior failure on three or mor...
Therapeutic Area
Central nervous system
Status Description
Routinely available in line with national guidance
Formulation
Oral lyophilisate
Comments
Link to Advice
Advice Published
11/09/2023
SMC Submission Type
Resubmission
SMC Status
Restricted